- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03503981
Examining Change Mechanisms in Psychotherapy (CAMP)
Examining Change Mechanisms in Psychotherapy: Relationship Between Specific Ingredients and Common Factors in Promoting Change.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a naturalistic study conducted by collecting data from in-patient units at Modum Bad (psychiatric hospital). The sample includes different patient groups with a variety of psychological disorders. Further, sample is gathered from units using different treatment approaches (short-term psychodynamic treatment, cognitive-behavioral treatment, metacognitive therapy, compassion-focused therapy, relational psychodynamic therapy, existential therapy and stabilizing trauma-therapy).
The following specific research questions will be explored:
The role of common factors:
- What are the relative influences of different common factors such as agreement on task and goals, treatment credibility and 'the real relationship', across treatments and diagnoses?
- Do some common factor variables stand out regarding ability to explain variance in outcome and across outcomes?
- Do measures of common factors have a consistent effect on outcome across treatment models and diagnoses, or does the explanatory value of common factors vary across diagnose and treatment model?
The role of specific change mechanisms (affective, cognitive and meta-cognitive):
- To what extent do specific change mechanisms predict change in various outcome domains?
- Are these specific change mechanisms equally important predictors, or do they vary across treatment or diagnose?
- Are there interaction effects between common factors and specific factors across treatment models, patient diagnoses and outcome domain?
Self-report data will be collected three times a week on mechanisms of change and symptoms, established by psychotherapy theory and research evidence as important for psychological change. The data collection consists of three different forms administered once per week on different days. The forms are separated by topic; symptoms, contextual factors, and change processes. The questions in the forms are selected from short instruments with good psychometric qualities. The data collection procedure has at present been tested on five patient cohorts with good results.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Ingvild Finsrud, Master degree
- Phone Number: 0047 95899278
- Email: ingvilfi@gmail.com
Study Locations
-
-
Buskerud
-
Vikersund, Buskerud, Norway, 3370
- Recruiting
- Modum Bad
-
Contact:
- Terje Tilden, PhD
- Phone Number: 0047 32749869
- Email: tilden@modum-bad.no
-
Principal Investigator:
- Ingvild Finsrud, Master
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
All patients accepted for inpatient treatment at Modum Bad Psychiatric hospital during the time of data collection will participate in this study, contingent on consent.
The patients included will be all genders, adults and reciving treatment from specialist health care.
Description
Inclusion Criteria:
- Must be a patient at Modum Bad
- Have a psychological disorder
Must have rights to treatment according to the rules of specialist health care in Norway. Includes the following:
- Patient is expected to have poorer prognosis of life quality if not given treatment
- It is expected that the patient will benefit from treatment
- It is expected that there is a reasonable cost-effect balance regarding the treatment given and the patient's benefit from treatment.
Exclusion Criteria:
- Acute suicidality
- Ongoing/active abuse of harmful drug(s)
- Under 18 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Anxiety unit
Patients have anxiety as a primary diagnose.
Receive treatment for anxiety (CBT and MCT).
|
There are different psychotherapy models offered across the units.
All patients receive individual treatment and group therapy or psychoeducative groups.
|
Eating disorder unit
Patients have eating disorder as primary diagnose.
Receive treatment for their eating disorder (CBT and compassion-focused therapy).
|
There are different psychotherapy models offered across the units.
All patients receive individual treatment and group therapy or psychoeducative groups.
|
Depression unit
Patients have depression as primary disorder.
Receive treatment for their depression (Short-term dynamic therapy, existential therapy and relational psychodynamic therapy).
|
There are different psychotherapy models offered across the units.
All patients receive individual treatment and group therapy or psychoeducative groups.
|
Family unit
One of the members of the family has a psychological disorder.
The treatment is focused towards the family and family dynamics.
|
There are different psychotherapy models offered across the units.
All patients receive individual treatment and group therapy or psychoeducative groups.
|
Trauma unit
Patients have PTSD and relational trauma as primary diagnosis.
Receive stabilizing treatment and exposure therapy.
|
There are different psychotherapy models offered across the units.
All patients receive individual treatment and group therapy or psychoeducative groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Symptom checklist revised (SCL-90-R)
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
|
A general measure of symptoms distress
|
Change measure (baseline, 14 weeks, and 12 months).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inventory of interpersonal problems
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
|
Self-report questionnaire of interpersonal problems
|
Change measure (baseline, 14 weeks, and 12 months).
|
Beck's depression inventory
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
|
Measure of depressive symptoms
|
Change measure (baseline, 14 weeks, and 12 months).
|
PTSD checklist for Diagnostic and Statistical Manual 5 (PCL-5)
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
|
PTSD symptom measure
|
Change measure (baseline, 14 weeks, and 12 months).
|
M-POQ outcome, anxiety
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Measures anxiety symptoms
|
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
M-POQ outcome, depression
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Measures depression symptoms
|
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
M-POQ outcome, loneliness
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Measures experienced loneliness
|
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
M-POQ outcome, resilience
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Measures experienced recilience
|
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
M-POQ outcome, well-being
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Measures experienced well-being
|
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Finsrud I, Nissen-Lie HA, Ulvenes P, Melsom L, Vrabel K, Wampold B. Confidence in the therapist and confidence in the treatment predict symptomatic improvement week by week in therapy: A latent curve modeling approach. J Couns Psychol. 2022 Nov;69(6):823-834. doi: 10.1037/cou0000640. Epub 2022 Sep 22.
- Finsrud I, Nissen-Lie HA, Vrabel K, Hostmaelingen A, Wampold BE, Ulvenes PG. It's the therapist and the treatment: The structure of common therapeutic relationship factors. Psychother Res. 2022 Feb;32(2):139-150. doi: 10.1080/10503307.2021.1916640. Epub 2021 May 2.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAMPFinsrud
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Psychotherapy
-
Universidade Federal do Rio de JaneiroCompleted
-
Randi UlbergUniversity of OsloCompleted
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Marianne Lau, MD, DSci.The Ministry of Science, Technology and Innovation, DenmarkUnknownBulimia Nervosa (BN) | Binge Eating Disorder (BED) | Eating Disorder Not Otherwise Specified (EDNOS)Denmark
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
University Hospital FreiburgCompletedChronic Major Depressive DisorderGermany
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityUnknown
-
Memorial Sloan Kettering Cancer CenterUniversity of Manitoba; National Cancer Institute (NCI); Visiting Nurse Service... and other collaboratorsCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCentral Hospital, Nancy, France; University of LorraineCompletedBreast Cancer FemaleFrance
-
Weill Medical College of Cornell UniversityUnknownIdentity Pathology | Behavior ProblemsUnited States